These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 30315933)

  • 1. The multiple protective roles and molecular mechanisms of melatonin and its precursor N-acetylserotonin in targeting brain injury and liver damage and in maintaining bone health.
    Luo C; Yang Q; Liu Y; Zhou S; Jiang J; Reiter RJ; Bhattacharya P; Cui Y; Yang H; Ma H; Yao J; Lawler SE; Zhang X; Fu J; Rozental R; Aly H; Johnson MD; Chiocca EA; Wang X
    Free Radic Biol Med; 2019 Jan; 130():215-233. PubMed ID: 30315933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two indoleamines are secreted from rat pineal gland at night and act on melatonin receptors but are not night hormones.
    Lee BH; Bussi IL; de la Iglesia HO; Hague C; Koh DS; Hille B
    J Pineal Res; 2020 Mar; 68(2):e12622. PubMed ID: 31715643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia.
    Kilic U; Yilmaz B; Ugur M; Yüksel A; Reiter RJ; Hermann DM; Kilic E
    J Pineal Res; 2012 Mar; 52(2):228-35. PubMed ID: 21913972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular and chemical perspective in defining melatonin receptor subtype selectivity.
    Chan KH; Wong YH
    Int J Mol Sci; 2013 Sep; 14(9):18385-406. PubMed ID: 24018885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of melatonin receptor 2 but not melatonin receptor 1 mediates melatonin-conferred cardioprotection against myocardial ischemia/reperfusion injury.
    Han D; Wang Y; Chen J; Zhang J; Yu P; Zhang R; Li S; Tao B; Wang Y; Qiu Y; Xu M; Gao E; Cao F
    J Pineal Res; 2019 Aug; 67(1):e12571. PubMed ID: 30903623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of bone mass through pineal-derived melatonin-MT2 receptor pathway.
    Sharan K; Lewis K; Furukawa T; Yadav VK
    J Pineal Res; 2017 Sep; 63(2):. PubMed ID: 28512916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin receptors: role on sleep and circadian rhythm regulation.
    Dubocovich ML
    Sleep Med; 2007 Dec; 8 Suppl 3():34-42. PubMed ID: 18032103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin receptor activation provides cerebral protection after traumatic brain injury by mitigating oxidative stress and inflammation via the Nrf2 signaling pathway.
    Wang J; Jiang C; Zhang K; Lan X; Chen X; Zang W; Wang Z; Guan F; Zhu C; Yang X; Lu H; Wang J
    Free Radic Biol Med; 2019 Feb; 131():345-355. PubMed ID: 30553970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new perspective in Oral health: potential importance and actions of melatonin receptors MT1, MT2, MT3, and RZR/ROR in the oral cavity.
    Cutando A; Aneiros-Fernández J; López-Valverde A; Arias-Santiago S; Aneiros-Cachaza J; Reiter RJ
    Arch Oral Biol; 2011 Oct; 56(10):944-50. PubMed ID: 21459362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin in cardiovascular disease.
    Dominguez-Rodriguez A
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1593-6. PubMed ID: 22916801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin and alcohol-related disorders.
    Kurhaluk N; Tkachenko H
    Chronobiol Int; 2020 Jun; 37(6):781-803. PubMed ID: 32419511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylserotonin: neuroprotection, neurogenesis, and the sleepy brain.
    Tosini G; Ye K; Iuvone PM
    Neuroscientist; 2012 Dec; 18(6):645-53. PubMed ID: 22585341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of N-acetylserotonin and melatonin alleviate chronic ketamine-induced behavioural phenotype accompanying BDNF-independent and dependent converging cytoprotective mechanisms in the hippocampus.
    Choudhury A; Singh S; Palit G; Shukla S; Ganguly S
    Behav Brain Res; 2016 Jan; 297():204-12. PubMed ID: 26475510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant effects of N-acetylserotonin: possible mechanisms and clinical implications.
    Oxenkrug G
    Ann N Y Acad Sci; 2005 Aug; 1053():334-47. PubMed ID: 16179540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective Effects of N-acetylserotonin and Its Derivative.
    Kang JH; Guo XD; Wang YD; Kang XW
    Neuroscience; 2023 May; 517():18-25. PubMed ID: 36893983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin MT
    López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylserotonin activates TrkB receptor in a circadian rhythm.
    Jang SW; Liu X; Pradoldej S; Tosini G; Chang Q; Iuvone PM; Ye K
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3876-81. PubMed ID: 20133677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylserotonin: circadian activation of the BDNF receptor and neuroprotection in the retina and brain.
    Iuvone PM; Boatright JH; Tosini G; Ye K
    Adv Exp Med Biol; 2014; 801():765-71. PubMed ID: 24664769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression.
    Wu YH; Ursinus J; Zhou JN; Scheer FA; Ai-Min B; Jockers R; van Heerikhuize J; Swaab DF
    J Affect Disord; 2013 Jun; 148(2-3):357-67. PubMed ID: 23357659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin Receptor as a Drug Target for Neuroprotection.
    Wongprayoon P; Govitrapong P
    Curr Mol Pharmacol; 2021; 14(2):150-164. PubMed ID: 32316905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.